MediWound (MDWD) Other Non-Current Liabilities (2013 - 2026)
MediWound (MDWD) posted quarterly Other Non-Current Liabilities of $8.3 million for Q4 2025, up 1.74% year-over-year from $8.1 million in Q4 2024, and down 2.78% quarter-over-quarter from $8.5 million in Q3 2025.
MediWound (MDWD) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
MediWound's Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $8.3 million for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities rose 1.74% year-over-year to $8.3 million; the TTM figure through Dec 2025 stood at $8.3 million (up 1.74% YoY), while the FY2025 annual figure was $8.3 million, up 1.74% from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $8.3 million, down from $8.5 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $8.5 million in Q3 2025, with the low at -$944000.0 in Q4 2022.
- The 5-year median for Other Non-Current Liabilities is $7.9 million (2021), against an average of $7.2 million.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities sank 111.97% in 2022, then surged 1808.43% in 2024.
- MediWound's Other Non-Current Liabilities stood at $7.9 million in 2021, then tumbled by 111.97% to -$944000.0 in 2022, then jumped by 145.23% to $427000.0 in 2023, then soared by 1808.43% to $8.1 million in 2024, then grew by 1.74% to $8.3 million in 2025.
- Business Quant data shows MDWD's Other Non-Current Liabilities at $8.3 million in Q4 2025, $8.5 million in Q3 2025, and $8.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.78 Mn |
| Dec 31, 2025 | 8.29 Mn |
| Sep 30, 2025 | 8.53 Mn |
| Jun 30, 2025 | 8.50 Mn |
| Mar 31, 2025 | 8.31 Mn |
| Dec 31, 2024 | 8.15 Mn |
| Sep 30, 2024 | 8.05 Mn |
| Jun 30, 2024 | 8.01 Mn |
| Mar 31, 2024 | 7.78 Mn |
| Dec 31, 2023 | 427,000.00 |
| Sep 30, 2023 | 7.86 Mn |
| Jun 30, 2023 | 7.81 Mn |
| Mar 31, 2023 | 7.58 Mn |
| Dec 31, 2022 | -944,000.00 |
| Sep 30, 2022 | 8.45 Mn |
| Jun 30, 2022 | 8.13 Mn |
| Mar 31, 2022 | 7.90 Mn |
| Dec 31, 2021 | 7.89 Mn |
| Sep 30, 2021 | 7.72 Mn |
| Jun 30, 2021 | 7.67 Mn |